These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19700066)

  • 21. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.
    de Boer IH; Steffes MW
    J Am Soc Nephrol; 2007 Apr; 18(4):1036-7. PubMed ID: 17360946
    [No Abstract]   [Full Text] [Related]  

  • 22. [Star disease: diabetic nephropathy].
    Cordonnier D
    Nephrologie; 2002; 23(2):73-6. PubMed ID: 12012751
    [No Abstract]   [Full Text] [Related]  

  • 23. Finerenone for Albuminuria in Patients With Diabetic Nephropathy.
    Feng Y; Zeng X; Fu P
    JAMA; 2016 Jan; 315(3):305-6. PubMed ID: 26784783
    [No Abstract]   [Full Text] [Related]  

  • 24. Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
    Bakris GL; Nowack C
    JAMA; 2016 Jan; 315(3):306. PubMed ID: 26784785
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study.
    Leung WK; Gao L; Siu PM; Lai CW
    Life Sci; 2016 Dec; 166():121-130. PubMed ID: 27765534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic nephropathy: Nonsteroidal MRA added to RAS blockade reduces albuminuria.
    Weir MR
    Nat Rev Nephrol; 2015 Dec; 11(12):691-2. PubMed ID: 26460357
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral hypoglycemics and diabetic nephropathy.
    Hadler NM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):159-62. PubMed ID: 18178782
    [No Abstract]   [Full Text] [Related]  

  • 29. Glomerular endothelial dysfunction in type 2 diabetes mellitus.
    Futrakul N; Butthep P; Futrakul P; Sittipreja V
    Ren Fail; 2006; 28(6):523-4. PubMed ID: 16928624
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
    Khan AH; Sattar MA; Abdullah NA; Johns EJ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):501-8. PubMed ID: 19673932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
    Postma MJ; Boersma C; Gansevoort RT
    Nephrol Dial Transplant; 2008 Apr; 23(4):1103-6. PubMed ID: 17210586
    [No Abstract]   [Full Text] [Related]  

  • 32. Nephropathy in type 2 diabetes.
    Mora C; Garcia J; Navarro JF
    N Engl J Med; 2000 Feb; 342(6):441; author reply 442. PubMed ID: 10681230
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetic Nephropathy: From Pathophysiology to Treatment.
    Shen Z; Fang Y; Xing T; Wang F
    J Diabetes Res; 2017; 2017():2379432. PubMed ID: 29201920
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
    Nasrallah R; Robertson SJ; Hébert RL
    Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance, kidney damage, and gender.
    Kordella T
    Diabetes Forecast; 2005 Sep; 58(9):40. PubMed ID: 16187434
    [No Abstract]   [Full Text] [Related]  

  • 38. Mortality in type 2 diabetes mellitus.
    Hollenberg NK
    J Hypertens; 2007 Dec; 25(12):2381-2. PubMed ID: 17984657
    [No Abstract]   [Full Text] [Related]  

  • 39. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus.
    Postma MJ; de Zeeuw D
    Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetic and hypertensive nephropathy in India.
    Acharya VN
    J Assoc Physicians India; 2011 Mar; 59():143. PubMed ID: 21751620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.